Top Ten most popular articles on Pharmafile.com this week!
April 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma
This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
NICE recommends UCB’s Cimzia in severe plaque psoriasis
April 18, 2019Sales and Marketing Cimzia, NICE, UCB Pharma, UK, pharma, plaque psoriasis, psoriasis
NICE has announced its decision to recommend UCB Pharma’s Cimzia (certolizumab pegol) for use on the NHS in England in …
CBD could be used to deliver drugs into the brain, research shows
April 18, 2019Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience
Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …
Doctors cure ‘bubble boy syndrome’ using modified version of HIV
April 18, 2019Research and Development HIV, SCID-X1, gene therapy, immunodeficiency, immunology
Doctors at St. Jude Children’s Research Hospital have been able to treat patients with X-linked severe combined immunodeficiency (SCID-X1) – …
Insys Therapeutics names current CFO Andrew Long as company’s new CEO
April 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insys Therapeutics, appointment, pharma
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Imperial College London researchers developing tech to monitor dementia patients at home
April 17, 2019Research and Development dementia, imperial college london, pharma
Researchers at Imperial College London are hard at work developing technology to aid the lives of dementia patients in their …
MS Pharma ink deal for acquisition of Genepharm
April 17, 2019Research and Development
Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. …
NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease
April 17, 2019Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK
Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …
China introduces new laws to ensure steady supply of drugs
April 17, 2019Research and Development China, National Health Commission, laws, markets, pharma, regulation
China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …
GSK to make redundancies at plant in Stevenage
April 17, 2019Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage
GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …
Use of Genzyme’s MS drug Lemtrada restricted under ongoing EMA safety review
April 16, 2019Manufacturing and Production, Sales and Marketing EMA, Genzyme, Lemtrada, multiple sclerosis, pharma
The EMA has launched a review into Genzyme’s multiple sclerosis drug Lemtrada (alemtuzumab) after reports emerged of treatment-related safety issues …
Genentech employee awarded $250,000 over racial discrimination case
April 16, 2019Manufacturing and Production Genentech, discrimination, pharma, racial discrimination, racism
A US jury has awarded a former Genentech employee nearly $250,000 after the black worker was fired from the firm …
Insys Therapeutics names current CFO Andrew Long as company’s new CEO
April 16, 2019Manufacturing and Production CEO, Insys Therapeutics, Subsys, appointments, cfo, pharma
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Janssen’s Invokana combo smashes primary and secondary endpoints in chronic kidney disease
April 16, 2019Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma
Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the therapy …
Half of patients have sub-optimal response to statins, research shows
April 16, 2019Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …
Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine
April 15, 2019Research and Development, Sales and Marketing Pfizer, Streptococcus pneumoniae, Vaccine, pharma
Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC), detailing the …
Bowel cancers adjust themselves to hide from immunotherapies
April 15, 2019Sales and Marketing CEA, Cancer, bowel cancer, immunotherapy, oncology, tumour
Bowel cancers can avoid being caught by immunotherapy by ‘switching off’ a molecule on the surface of cells that is …
Doctors treat porphyria using innovative gene silencing drug
April 15, 2019Sales and Marketing RNA, gene silencing, genetics, givosiran, health, porphyria
Doctors have successfully treated porphyria using an innovative ‘gene-silencing’ drug. Speaking to the BBC, Professor David Rees, from King’s College …
Janssen’s Balversa becomes first FDA-approved FGFR kinase inhibitor for advanced bladder cancer
April 15, 2019Sales and Marketing Balversa, Cancer, FDA, Janssen, bladder cancer, pharma
Janssen’s Balversa (erdafitinib) has become the first FDA-approved fibroblast growth factor receptor (FGFR) kinase inhibitor after the US agency authorised …
Medical cannabis: A green light for patients in need?
April 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma
Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
